Ectoparasiticides and Special Topics

Correct Answer

B — Pyrethroid

Rationale

Permethrin is a synthetic pyrethroid — a class of insecticides and acaricides derived from the natural pyrethrins found in Chrysanthemum flowers. Pyrethroids act on voltage-gated sodium channels in arthropod nerve membranes. Permethrin is the first-line topical treatment for both scabies and pediculosis. Organophosphates (malathion) act by inhibiting acetylcholinesterase. Macrocyclic lactones (ivermectin) open glutamate-gated chloride channels. Benzimidazoles (mebendazole, albendazole) act by inhibiting tubulin polymerization in helminths and are not ectoparasiticides.

Correct Answer

C — Crusted scabies, where the massive mite burden and hyperkeratotic skin make topical agents insufficient alone

Rationale

Oral ivermectin is indicated for crusted (Norwegian) scabies — a severe form of scabies occurring in immunocompromised or institutionalized patients in which millions of mites colonize thickened, hyperkeratotic skin. Topical permethrin cannot penetrate the thick crust reliably, so systemic ivermectin is added to reach mites throughout the skin via the circulation. Oral ivermectin is also used for ordinary scabies when topical treatment fails or is impractical. Ivermectin is not a first-line treatment for pediculosis capitis (permethrin is), is not used for malaria prophylaxis, and has ectoparasitic indications beyond intestinal nematodes.

Correct Answer

A — Alternative scabicide with a distinct chemical structure from pyrethroids and macrocyclic lactones

Rationale

Benzyl benzoate is an aromatic ester used as a topical scabicide and pediculicide. It is structurally and mechanistically distinct from the pyrethroids (permethrin), macrocyclic lactones (ivermectin), and organophosphates (malathion). It is used primarily as an alternative agent in resource-limited settings where permethrin may be unavailable or unaffordable, and is applied as a lotion over the entire body surface. It is not a pyrethroid, not a macrocyclic lactone, and not a benzimidazole — the benzimidazole class refers to anthelmintic agents such as mebendazole and albendazole, which have no acaricidal activity.

Correct Answer

D — A synergist that inhibits insect enzymes responsible for metabolizing and inactivating pyrethrins, thereby increasing their effective concentration

Rationale

Piperonyl butoxide is not itself an insecticide — it has no direct killing activity. Its role is that of a synergist: it inhibits the cytochrome P450 monooxygenase enzymes in insects that would otherwise rapidly metabolize and inactivate pyrethrins. By blocking this detoxification pathway, piperonyl butoxide allows pyrethrins to persist at higher concentrations in the insect, amplifying their insecticidal effect. This is why pyrethrin-based pediculicide formulations almost always include piperonyl butoxide as a combined ingredient. Piperonyl butoxide does not open sodium channels independently, has no anthelmintic activity, and does not act as a penetration enhancer.

Correct Answer

B — Organophosphate

Rationale

Malathion is an organophosphate compound used as a pediculicide for head lice, particularly in cases where pyrethroid resistance is suspected or confirmed. Organophosphates act by inhibiting acetylcholinesterase, causing accumulation of acetylcholine at nerve synapses and producing continuous nerve stimulation, paralysis, and death in the arthropod. Malathion is selectively toxic to insects relative to mammals because human plasma esterases rapidly hydrolyze malathion before significant acetylcholinesterase inhibition can occur. Pyrethroids (permethrin), macrocyclic lactones (ivermectin), and benzimidazoles (mebendazole) each represent distinct drug classes with different mechanisms.

Correct Answer

C — Spinosad is a naturally derived pediculicide that activates nicotinic acetylcholine receptors and allosterically potentiates gamma-aminobutyric acid receptors, giving it a mechanism distinct from both pyrethroids and organophosphates

Rationale

Spinosad is derived from the soil bacterium Saccharopolyspora spinosa and belongs to the spinosyn class. Its dual mechanism — nicotinic acetylcholine receptor activation combined with gamma-aminobutyric acid receptor potentiation — produces rapid insect nerve hyperexcitation followed by paralysis. Because its mechanism does not involve voltage-gated sodium channels, spinosad retains full activity against lice with knockdown resistance to pyrethroids. It is also not an organophosphate and does not inhibit acetylcholinesterase. Spinosad is not a benzimidazole and does not inhibit tubulin. Its distinct mechanism makes it a useful alternative when pyrethroid resistance is present.

Correct Answer

A — Permethrin binds to voltage-gated sodium channels in arthropod nerve membranes, holding them in the open state and causing prolonged depolarization, repetitive nerve firing, paralysis, and death

Rationale

Pyrethroids including permethrin act by binding to voltage-gated sodium channels and stabilizing them in the open conformation. In a normal nerve, sodium channels open briefly in response to a stimulus and then rapidly inactivate. Permethrin prevents inactivation, so sodium continues to flow into the cell, producing prolonged membrane depolarization and repetitive, uncontrolled nerve firing. The arthropod is paralyzed and dies. This mechanism is shared by all pyrethroids. Acetylcholinesterase inhibition describes organophosphates such as malathion. Glutamate-gated chloride channel opening describes ivermectin. Cuticle disruption is not the mechanism of permethrin.

Correct Answer

C — Point mutations in the voltage-gated sodium channel reduce permethrin's binding affinity, so the channel is no longer held open and the insecticidal effect is lost

Rationale

Knockdown resistance — named for the original observation that resistant insects did not fall when exposed to pyrethroid insecticides — is caused by point mutations in the voltage-gated sodium channel gene. These mutations alter the structure of the channel at or near the pyrethroid binding site, reducing the affinity with which permethrin can bind and stabilize the open state. Because permethrin can no longer hold the channel open effectively, the prolonged depolarization required for insecticidal activity does not occur. Knockdown resistance is the primary mechanism of pyrethroid resistance in lice worldwide. It is not caused by esterase-mediated drug hydrolysis, thickened cuticle, or acetylcholinesterase overexpression.

Correct Answer

B — Piperonyl butoxide inhibits the cytochrome P450 monooxygenase enzymes in insects that would otherwise metabolize and inactivate pyrethrins, prolonging pyrethrin activity and enhancing the insecticidal effect

Rationale

Pyrethrins are natural compounds that insects can partially detoxify through oxidative metabolism catalyzed by cytochrome P450 monooxygenase enzymes. Piperonyl butoxide inhibits these enzymes, preventing the insect from breaking down pyrethrins and allowing them to accumulate at higher concentrations at their sodium channel target. This synergistic effect makes pyrethrin-piperonyl butoxide combinations substantially more effective than pyrethrins alone. Piperonyl butoxide has no direct sodium channel activity, no effect on drug solubility in the formulation vehicle, and does not inhibit acetylcholinesterase.

Correct Answer

D — The massive mite burden in crusted scabies resides deep within thick hyperkeratotic skin that topical agents cannot reliably penetrate; systemic ivermectin reaches mites throughout the skin via the bloodstream

Rationale

Crusted scabies, also called Norwegian scabies, differs from ordinary scabies in that the mite burden is dramatically higher — thousands to millions of mites rather than the tens to hundreds found in typical infestation. These mites colonize and proliferate within thick, scaly, hyperkeratotic skin that acts as a physical barrier to topical drug penetration. Topical permethrin applied to the surface cannot reliably reach mites deep within the crust. Oral ivermectin distributes systemically and reaches mites in all skin compartments through the circulation, bypassing the penetration problem. Combination therapy is standard because topical treatment addresses surface mites while systemic therapy reaches those beyond topical reach. Knockdown resistance is not the basis for adding ivermectin in this setting, permethrin is not contraindicated in immunocompromised patients, and duration of action does not drive the clinical decision to add systemic therapy.

Correct Answer

A — Chloroquine is considered safe throughout pregnancy; artemisinin-based combination therapy is avoided in the first trimester due to embryotoxicity concerns but is used in the second and third trimesters; quinine plus clindamycin is the preferred alternative in the first trimester for falciparum malaria

Rationale

Antimalarial drug selection in pregnancy is trimester-dependent. Chloroquine has a long safety record in pregnancy and is used throughout all three trimesters for susceptible Plasmodium vivax and Plasmodium ovale infections. Artemisinin-based combination therapy is the most effective treatment for Plasmodium falciparum malaria and is used in the second and third trimesters, but is avoided in the first trimester because artemisinin compounds have shown embryotoxic effects in animal models during early organogenesis. For first-trimester falciparum malaria, the recommended regimen is quinine plus clindamycin. Mefloquine has no pregnancy category A designation and is not the preferred agent across all trimesters. Treatment of malaria in pregnancy is never deferred regardless of trimester, as untreated malaria carries serious maternal and fetal risks.

Correct Answer

C — Benzimidazoles have shown teratogenic and embryotoxic effects in animal studies, so treatment is deferred until the second trimester when organogenesis is complete

Rationale

Albendazole and mebendazole have demonstrated teratogenic and embryotoxic effects in animal reproduction studies — findings attributed to their mechanism of disrupting microtubule-dependent cell division processes during organogenesis. Although the clinical relevance in humans at single-dose mass drug administration levels is uncertain, the precautionary principle is applied: mass drug administration programs withhold benzimidazole treatment in women in the first trimester and resume in the second trimester, after the period of greatest teratogenic risk has passed. This is a pregnancy safety classification precaution, not a pharmacokinetic or metabolic issue, and not related to amniotic fluid drug accumulation.

Correct Answer

B — Metronidazole is hepatically metabolized, and its reactive metabolites can accumulate in patients with impaired liver function, increasing the risk of hepatotoxicity

Rationale

Metronidazole undergoes extensive hepatic metabolism, and the same reactive intermediates responsible for its antiprotozoal and antibacterial activity can cause hepatocellular injury when they accumulate. In patients with normal liver function, these metabolites are efficiently processed and eliminated. In patients with hepatic impairment — whether from cirrhosis, severe hepatitis, or other liver disease — reduced metabolic capacity leads to drug and metabolite accumulation, prolonging exposure and increasing hepatotoxicity risk. Dose reduction is recommended in severe hepatic impairment. Metronidazole does not directly inhibit bile acid synthesis, does not concentrate in bile to cause duct injury, and its relationship to fibrosis progression is not an established clinical concern at standard doses.

Correct Answer

D — P-glycoprotein at the blood-brain barrier normally pumps ivermectin out of the central nervous system; patients with reduced P-glycoprotein function accumulate ivermectin in brain tissue and may develop central nervous system toxicity at standard doses

Rationale

Ivermectin does enter vertebrate brain tissue, but P-glycoprotein — an efflux transporter expressed at high levels in blood-brain barrier endothelial cells — actively pumps it back out, maintaining central nervous system concentrations below toxic levels under normal circumstances. This efflux mechanism is the basis for ivermectin's wide therapeutic window in vertebrates at standard doses. Patients with reduced P-glycoprotein function at the blood-brain barrier cannot clear ivermectin from the central nervous system at the normal rate; the drug accumulates and can cause ataxia, sedation, and in severe cases coma. Certain dog breeds share this pharmacological vulnerability, which first drew attention to the P-glycoprotein efflux mechanism. Plasma enzyme inactivation does not account for ivermectin's central nervous system safety. Ivermectin does cross the blood-brain barrier — P-glycoprotein is what limits its accumulation there. Gamma-aminobutyric acid receptor sensitivity variants are not the established explanation for ivermectin toxicity risk.

Correct Answer

A — The lice likely carry sodium channel mutations that reduce permethrin's ability to hold the channel open; spinosad acts through a different mechanism and retains full activity against permethrin-resistant lice

Rationale

Repeated permethrin treatment failure in a correctly treated patient is the clinical signature of knockdown resistance. Lice with sodium channel mutations can no longer be paralyzed by permethrin because the drug cannot stabilize the channel in the open state effectively. Recognizing this pattern guides the treatment switch: the appropriate response is to change to an agent with a different mechanism rather than repeat another permethrin course. Spinosad acts through nicotinic acetylcholine receptor activation and gamma-aminobutyric acid receptor potentiation — a mechanism entirely unrelated to sodium channels — and therefore retains full activity against knockdown-resistant lice. Malathion is another appropriate alternative via its organophosphate mechanism. Permethrin does have activity against hatched lice, not only eggs. The failure is not attributable to allergy or to the absence of piperonyl butoxide.

Correct Answer

C — Artemisinin-based combination therapy is appropriate at 18 weeks; it is avoided in the first trimester due to embryotoxicity concerns but is the treatment of choice for falciparum malaria in the second and third trimesters

Rationale

Artemisinin-based combination therapy is the most effective treatment for Plasmodium falciparum malaria and is used in the second and third trimesters of pregnancy when the benefit of treating a life-threatening infection outweighs the residual uncertainty about fetal risk. The concern about artemisinin compounds is concentrated in the first trimester, when animal studies showed embryotoxic effects during organogenesis; by the second trimester, organogenesis is complete and this risk is no longer the dominant concern. This patient at 18 weeks is beyond the first trimester and artemisinin-based combination therapy is appropriate. Deferring treatment is never acceptable in malaria — untreated falciparum malaria in pregnancy carries high risks of severe maternal disease, preterm birth, and fetal loss. Chloroquine is used throughout pregnancy for susceptible Plasmodium vivax and ovale infections but is not effective against the vast majority of Plasmodium falciparum due to widespread resistance.

Correct Answer

B — Rifampin induces hepatic drug-metabolizing enzymes, accelerating praziquantel clearance and reducing plasma concentrations below the level needed to kill schistosomes

Rationale

Rifampin is one of the most potent inducers of hepatic cytochrome P450 enzymes in clinical use. When co-administered with praziquantel, rifampin dramatically accelerates praziquantel metabolism, reducing peak plasma concentrations by the large majority of what they would be without the interaction. The result is subtherapeutic praziquantel exposure — the drug is present but at concentrations insufficient to kill schistosomes reliably, producing clinical treatment failure despite a complete and correctly dosed course. This interaction is clinically important because tuberculosis and schistosomiasis co-occur extensively in sub-Saharan Africa. When both infections require simultaneous treatment, praziquantel dose adjustment or careful timing around rifampin dosing may be necessary. Rifampin does not compete at schistosomal calcium channels, does not affect urinary drug trapping, and has no meaningful antischistosomal activity.

Correct Answer

D — Permethrin has minimal dermal absorption and a well-established safety profile in pregnancy; malathion is an organophosphate with systemic absorption potential and cholinesterase-inhibiting properties that raise greater pregnancy safety concerns

Rationale

When treating head lice during pregnancy, the choice between permethrin and malathion reflects their relative safety profiles for the mother and fetus. Permethrin is a pyrethroid with very low dermal absorption — only a small fraction of a topically applied dose enters systemic circulation — and it has been used extensively in pregnancy without signals of fetal harm. Malathion is an organophosphate; while dermal absorption is limited with correct use, the drug class carries systemic cholinesterase-inhibiting properties and a less well-characterized pregnancy safety record than permethrin. For this reason, permethrin is the preferred first-line topical pediculicide in pregnancy. The concern about malathion is its mechanism and pharmacokinetic profile as a class, not specific irreversible neonatal effects from proximity to delivery, alcohol vehicle absorption, or comparative efficacy differences — permethrin and malathion are both effective against susceptible lice.